Literature DB >> 33013034

Continuous preperitoneal infusion of ropivacaine for postoperative analgesia in patients undergoing major abdominal or pelvic surgeries. A prospective controlled randomized study.

Reem Abdelraouf ElSharkawy1, Tamer Elmetwally Farahat1, Khaled Abdelwahab2.   

Abstract

BACKGROUND AND AIMS: This study was conducted to compare continuous preperitoneal infusion (CPI) with continuous epidural infusion (CEI) of ropivacaine for pain relief and effect on pulmonary functions after major abdominal and pelvic surgeries.
MATERIAL AND METHODS: One hundred patients were randomized into two equal groups. Patients in CPI group (n = 50) received analgesia by continuous infusion of 0.2% ropivacaine, whereas those in the CEI group (n = 50) received continuous epidural infusion of 0.2% ropivacaine. The primary outcome was the first request of analgesia. The secondary outcome was the influence on the pulmonary functions.
RESULTS: The time for the first request of analgesia was longer in the CPI group compared with that in the CEI group (7.3 ± 1.6 vs. 4.1 ± 1.1 h with P value = 0.001). The daily dose of morphine was lesser in CPI versus CEI group (11.3 ± 1 against 17.4 ± 0.9 mg). The pulmonary function tests were comparable except peak expiratory flow rate, which was better in CPI (170 ± 5.4) than CEI group (148.1 ± 5.8; with P value = 0.001).
CONCLUSION: Continuous preperitoneal infusion provides a superior analgesic effect than the continuous epidural infusion as regards delayed first request of analgesia, better pain scores, lesser usage of additional analgesics with better respiratory function. Copyright:
© 2020 Journal of Anaesthesiology Clinical Pharmacology.

Entities:  

Keywords:  Abdominal tumors; epidural infusion; pelvic tumors and ropivacaine; preperitoneal infusion

Year:  2020        PMID: 33013034      PMCID: PMC7480288          DOI: 10.4103/joacp.JOACP_333_18

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


Introduction

Pain from major abdominal or pelvic surgeries is severe and increases in intensity during mobilization.[1] This pain increases perioperative complications, healthcare costs, and even mortality. Consequently, adequate management of postoperative pain is mandatory.[2] Continuous epidural infusion (CEI) is still the gold standard analgesic technique in abdominal surgeries. It offers a superior analgesic effect than systemic administration of opioid.[3] However, CEI is associated with 5-25% risk of failure[4] and may be associated with complications such as respiratory depression, hypotension, urinary retention, epidural hematoma, or inadequate analgesic distribution.[56] Continuous preperitoneal infusion (CPI) with local anesthetics is characterized by effectiveness, simplicity, and safety[7] It is superior to systemic opioids.[8] In addition, CPI has a very low rate of technical failure (~1%) and zero toxicity.[9] Existing literature comparing CPI and CEI shows varying results, from superiority of CEI[1011] to superiority of CPI.[121314] Therefore, this prospective study was planned to compare CEI and CPI with regard to the postoperative pain relief measured by the postoperative opioid requirements and the time of the first analgesic request. We also recorded the changes in respiratory function and haemodynamics with both techniques.

Material and Methods

This prospective randomized study was conducted between June 2015 and July 2018 after receiving the approval from local institutional review board with the coded number (R/15.05.03). Patients of both sexes aged 18–80 years and ASA physical status I or II who were to undergo elective open resection of abdominal tumors through a periumbilical midline incision were invited to participate in this study. Patients who refused to participate, those with pregnancy, or any contraindication for the epidural catheter, those with a known history of sensitivity to any of the local anesthetics used, moderate to severe respiratory dysfunction, active drug addiction or ongoing treatment with opiates, and those with inability to communicate or mental disorders or disturbed consciousness were excluded from the study. Lastly, patients in whom separate closure of the peritoneum was not possible due to previous surgery and those scheduled for laparoscopic surgery were also excluded. In the preoperative visit, the study protocol and the linear Visual Analogue Scale (VAS) were explained to every patient using a graded ruler from 0 to 10. A written informed consent was signed by every patient. All patients received 0.02 mg/kg midazolam as premedication the night before the operation. In the operation theater, basic monitors were applied and basal vital parameters were monitored and recorded. Oxygen was provided via face mask (6 L/min) for 5 min before induction of anesthesia. Infusion of Ringer's Lactate solution at a rate of 5 mL/kg via 18-gauge cannula was done. Randomization was done by a computer-generated randomization sequence. The staff member who performed the randomization sequence had no clinical knowledge of the study and was not involved with patient recruitment or data collection. Allocation concealment was achieved by the usage of opaque and sealed envelopes. Participants were randomly allocated into two equal groups, 50 patients in every group. The first group received the analgesia via CPI (n = 50): The epidural catheter was inserted between the parietal peritoneum and the transversalis fascia during the closing of the wound with 10 mL of ropivacaine 0.2% followed by a continuous infusion of ropivacaine 0.2% at the rate of 5 mL/h through a syringe pump for the next 48 h. In the second group, the patients received analgesia via CEI (n = 50): The epidural catheter was inserted between T8 and T10 before induction of anesthesia and the patient received 10 mL of 2% ropivacaine as a test dose. Afterward a continuous infusion of ropivacaine 0.2% at the rate of 5 mL/h through a syringe pump for 48 h. Induction of anesthesia was accomplished with 2–3 μg/kg of fentanyl followed by intravenous propofol slowly (2 mg/kg) until loss of verbal contact. Tracheal intubation was facilitated with 0.5 mg/kg atracurium; one fifth of this dose was used for maintenance of muscle relaxation. The initial setting of mechanical ventilation was adjusted with tidal volume 8 mL/kg, respiratory rate 12 breath/min, positive end-expiratory pressure 5 cmH2O, and I/E ratio 1:2 aiming to maintain end tidal CO2~ 35 mmHg. Anesthesia was maintained with sevoflurane in O2/air mixture. Once the surgery ended, the neuromuscular residual blockade was reversed, with a mixture of neostigmine 0.04 mL/kg and atropine 0.02 mL/kg. Tracheal extubation was performed when the patient was conscious and breathing comfortably. During the wound closure, the single participating surgeon inserted a 16-gauge epidural catheter after creation of multiple perforations by 22 G needle, 1 cm apart until a length suitable for the wound. The catheter was inserted 3 cm away from the lower end of midline incision. A bacterial filter was fixed to the catheter. The catheter was positioned between the closed parietal peritoneum and the undersurface of the transversalis fascia, along the full length of the wound. Thereafter, the surgeon closed the wound in layers. The catheter was secured with a Steri-Strip and covered with a sterile transparent dressing independent of the wound. The anesthetic nurse injected the assigned bolus dose of the assigned solution through the catheter and connected with the syringe pump while the pump was set at a rate of 5 mL/h. The catheter was removed after 48 hours, after injection of the last dose and being sure of complete catheter extraction. The assessment of pain was done by the recorded visual analogue score (VAS) of pain at 1 h following transfer the patient to PACU then at 2,4,8,12, and 16 h. The pain assessment during rest and on coughing was recorded at 24 and 48 h postoperatively. If the recorded VAS was ≥3, a bolus dose of 5 mL of ropivacaine was given. Reassessment of VAS was done within 30 min and if VAS was still ≥3, one mg morphine was given intravenously as an analgesic rescue. The time of the first request of analgesia was recorded. Also, the dose of morphine used in the first and second postoperative day were recorded. The evaluation of respiratory functions was done by recording the respiratory rate preoperatively, and during the same time intervals of recorded VAS. Pulmonary function tests were done preoperatively, 24 and 48 h after the surgery by measuring forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) using a spirometer (SP10, CONTEC™). The ratio FEV1/FVC was calculated. The peak expiratory flow rate (PEFR) was recorded using a peak flow meter. The postoperative hemodynamic variables, which included the heart rate and mean arterial blood pressure were recorded at 1, 2, 4, 8, 12, 16, 24, and 48 h. C-reactive protein (CRP) was recorded 72-h postoperatively. Any other side effects were recorded such as nausea or vomiting, which necessitated treatment with intravenous 10 mg of metoclopramide.

Sample size calculation

The results of a pilot study showed 20% decrease of VAS at the fourth hour postoperative. The calculated effect size was 0.8, α error = 0.05, and the power of the study was 0.90. The calculated sample size was 88 cases, but there may be a 20% drop out rate. Therefore, we needed a total number of 100 cases (50 cases per group).

Statistical analysis

The data were analysed using SPSS version 20. The normality of the distribution of data was tested by Kolmogorov–Smirnov test. Mean ± standard deviation was used to describe the continuous or quantitative data, whereas the number and percentage were used to describe the categorical (qualitative) data. Association between these data was tested using Chi-square (χ2) or Fisher's exact test. Normally distributed data were tested using Student's t-test (unpaired), whereas Mann–Whitney U-test was used to test data with non-normal distribution. The P value was set at statistical significance of <0.05.

Results

During the period of the study, 150 patients were assessed for eligibility; 40 patients had one or more exclusion criteria. 10 patients refused to participate in this study. The demographics and surgical characteristics were comparable between the two groups [Table 1]. The table also shows the time to first analgesia, and the total morphine consumption on the first and second postoperative days. The CEI group had shorter analgesia and consumed more morphine on both postoperative days.
Table 1

Demographic and surgical characteristics. Data were presented in mean±SD or number and percentage of the patients

Group CPI (n=50)Group CEI (n=50)P
Demographics
 Age (years)46.8±7.045.6±6.90.4
 Gender (M/F)14/3311/370.4
 BMI (kg/m2)29.6±3.830.2+3.50.7
 ASA I31 (65.1%)32 (66.7%)0.9
 ASA II16 (34.0%)16 (33.3%)0.9
 Operative time (min)162±28.2156.52+33.40.3
 Length of the wound (cm)15.8±4.616.2±4.80.7
Type of tumor
 Uterine carcinoma13 (27.7%)15 (31.3%)
 Cancer colon13 (27.7%)11 (22.9%)0.9
 Ovarian cancer10 (21.3%)15 (31.3%)
 Urinary tumor11 (23.4%)7 (14.6%)
Tumor pathology
Malignant35370.7
Nonmalignant1211
First request of analgesia (h)7.3±1.64.07±1.1*0.001
The dose of morphine on the first postoperative day11.3±117.39±0.9*0.001
The dose of morphine on the second postoperative day7.06±0.913.25±0.9*0.001

SD: Standard deviation; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; BMI: Body mass index; ASA: American Society of Anesthesiologists. *P-value≤0.05: Statistically significant

Demographic and surgical characteristics. Data were presented in mean±SD or number and percentage of the patients SD: Standard deviation; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; BMI: Body mass index; ASA: American Society of Anesthesiologists. *P-value≤0.05: Statistically significant Table 2 shows the VAS scores in the two groups along with intergroup comparisons at different times. The CEI group had higher pain scores throughout the period of the study starting at 2 hours postoperative than CPI group.
Table 2

The postoperative assessment of pain within the studied groups measured by the visual analogue score (VAS). Data presented as median (IQR)

Group CPI (n=50)Group CEI (n=50)P


MedianIQRMedianIQR
1 h3(2-4)3(2-4)0.6
2 h3(2-4)3(2-4)0.7
4 h2(0-4)3(3-4)*0.001
8 h3(2-4)4(3-5)*0.001
12 h3(1-3)4(3-5)*0.001
16 h 2(1-3)3(2-4)*0.001
24 h at rest3(2-4)4(2-5)*0.001
24 h at cough3(4-5)4(4-5)*0.001
48 h at rest1(0-3)2(2-3)*0.001
48 h at cough2(2-4)3(3-4)*0.01

CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; CI: Confidence interval. *P-value ≤ 0.05: Statistically significant

The postoperative assessment of pain within the studied groups measured by the visual analogue score (VAS). Data presented as median (IQR) CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion; CI: Confidence interval. *P-value ≤ 0.05: Statistically significant CEI group had a lower respiratory, heart rate, and blood pressure starting at 2 hours postoperativethan CPE group [Figures 1 and 2].
Figure 1

The recorded changes in the respiratory rate in the studied groups

Figure 2

(a) The recorded changes of postoperative mean arterial blood pressure (mmHg) in the studied groups. (b) The recorded changes of postoperative heart rate (beat/min) in the studied groups

The recorded changes in the respiratory rate in the studied groups (a) The recorded changes of postoperative mean arterial blood pressure (mmHg) in the studied groups. (b) The recorded changes of postoperative heart rate (beat/min) in the studied groups Table 3 shows the respiratory functions and CRP values. The CEI group had a lower PEFR and CRP values than the CPI group.
Table 3

Preoperative and postoperative pulmonary function tests (FVC, FVE1), the ratio between them, PEFR, and CRP during the first 48 h. Data were expressed in mean±SD

Group CPI (n=50)Group CEI (n=50)P


MeanSDMeanSD
FVC (%)  Basal 24 h 86.1±2.987.3±2.9 87.0±2.887.5±3.0 0.80.7
 48 h87.8±2.887.4±2.90.5
FEV1 (%)
 Basal97.8±1.397.9±1.60.7
 24 h97.1±3.697.6±3.50.5
 48 h97.5±3.597.6±3.30.9
PEFR
 Basal282.0±6.4274.9±6.0*0.001
 24 h170.5±5.4148.1±5.8*0.001
 48 h191.8±6.7164.5±5.4*0.001
FEV1/FVC1.1±0.11.1±0.10.9
 Basal1.1±0.11.1±0.10.8
 24 h1.1±0.11.1±0.10.6
 48 h
 CRP35.3±3.839.9±5.9*0.001

FVC1: Forced vital capacity, FEV1: Forced expired volume, PEFR: Peak expiratory flow rate, CRP: C-reactive protein; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion. *P-value≤0.05: Statistically significant

Preoperative and postoperative pulmonary function tests (FVC, FVE1), the ratio between them, PEFR, and CRP during the first 48 h. Data were expressed in mean±SD FVC1: Forced vital capacity, FEV1: Forced expired volume, PEFR: Peak expiratory flow rate, CRP: C-reactive protein; CPI: Continuous preperitoneal infusion; CEI: Continuous epidural infusion. *P-value≤0.05: Statistically significant The incidence of nausea was comparable among the studied groups.: Seven patients (14%) in the CPI group with five vomiting compared to nine patients (18%) with nausea and five with vomiting in the CEI group.

Discussion

This prospective randomized study found that continuous peritoneal infusion (CPI) had a significant prolongation of the first analgesic request, more reduction of VAS of pain, and a reduction of analgesic consumption of morphine in comparison with CEI. Moreover, it resulted in better respiratory rates and respiratory functions with better stabilization of hemodynamics. Similar results exist in the literature. Bertoglio et al.[13] found a reduction of VAS in the CPI group without any difference in morphine consumption. Neil et al.[12] had similar results in full-term pregnant patients with continuous wound infiltration (CWI) being superior to CEI. Dhanapal et al.[14] also found CPI superior in terms of VAS scores and postoperative morphine consumption. On the other hand Jouve et al.[11] had recorded the reduction of median postoperative dynamic pain score in the CEI group than in CWI group [10 (0.6–20) vs. 37 (30–49) with P value <0.001]. However, this study was conducted on a small sample size of only 50 patients. Mouawad et al.[10] also demonstrated that the recorded pain scores were significantly higher in continuous preperitoneal wound catheter group when compared with continuous epidural group in the PACU and on the day of surgery, with similar secondary outcomes viz., postoperative complications, return of bowel function and length of hospital stay. Peritoneum plays an important role in pain perception after injury through a complex array of neuro-immuno-humoral cascades via secretion of various mediators responsible for systemic and local inflammatory response.[15] The neural pathway involves both vagal and spinal afferents. The release of pro-inflammatory cytokines sensitizes the peritoneum and results normal nonpainful stimuli being perceived as painful and in exaggeration of perception of painful stimuli. In addition, injury to the peritoneum causes changes in the central nervous system leading to an increase in spontaneous firing of wide dynamic neurons in the rat spinal dorsal horn.[16] We chose ropivacaine in this study due to its suppression of bradykinin and substance P-mediated signaling.[17] The anti-inflammatory effect of local anesthetic infusion was evident by the significant drop of CRP in the preperitoneal group. This is an additional benefit of CPI over CEI and may contribute to better analgesia. Sammour et al.[15] also concluded that the inflammatory response of peritonium to injury is the main central component of surgical stress. Various investigators have placed the catheter subcutaneously,[18] above the fascia,[19] below the fascia,[20] or in the preperitoneal space. Encouraging analgesic results have been seen when the catheter is placed deep to the fascia or in the preperitoneal space in patients undergoing midline laparotomy or open nephrectomy and renal transplant surgery.[2122] The better respiratory rate with CPI in our study may be due to the better analgesic effect of CPI, which influences better movement of the chest. However, Ozturk et al.[23] found no difference in FEV1 and FEV1/FVC between preperitoneal admnistration of levobupivacaine and isotonic saline. Sistla et al.[24] also concluded that there were no benefits in pulmonary function with intermittent wound perfusion with bupivacaine. Results of some studies were in contrast to our findings. Ozturk et al.[23] compared 10 mL of 0.25% levobupivacaine and 0.9% saline through preperitoneal wound catheter twice daily for 24 h postoperatively. They observed that the forced expiratory volumes in the first second (FEV1) and the ratio of FEV1/FVC were decreased from the preoperative values in both groups but were not different in the two groups (P = 0.4). Sistla et al.[24] also observed no beneficial effect of intermittent wound perfusion of bupivacaine on the pulmonary function. No hemodynamic complications were observed during the period of study. However, HR and MAP were significantly decreased in the CEI group but were still within normal limits.

Conclusion

In conclusion, continuous preperitoneal infusion of ropivacaine had a significant analgesic effect with decreased consumption of opioid and delayed request for additive analgesia with better respiratory function and better stability of hemodynamics compared to continuous epidural infusion.

Financial support and sponsorship

Nil.

Conflicts of interest

This research received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors. The authors have no financial or other conflict of interest to declare and no financial or other relationships leading to conflict of interest associated with publication of this manuscript. Manuscript had been read and approved by all authors, that the requirement for authorship. Each author believes that the manuscript represent honest work.
  23 in total

1.  Anesthesia and analgesia for colon surgery.

Authors:  Spencer S Liu
Journal:  Reg Anesth Pain Med       Date:  2004 Jan-Feb       Impact factor: 6.288

Review 2.  Persistent postsurgical pain: risk factors and prevention.

Authors:  Henrik Kehlet; Troels S Jensen; Clifford J Woolf
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

3.  The postoperative analgesic efficacy of preperitoneal continuous wound infusion compared to epidural continuous infusion with local anesthetics after colorectal cancer surgery: a randomized controlled multicenter study.

Authors:  Sergio Bertoglio; Fabio Fabiani; Pasquale De Negri; Antonio Corcione; Domenico Franco Merlo; Ferdinando Cafiero; Clelia Esposito; Claudio Belluco; Davide Pertile; Riccardo Amodio; Matilde Mannucci; Valeria Fontana; Marcello De Cicco; Lucia Zappi
Journal:  Anesth Analg       Date:  2012-11-09       Impact factor: 5.108

4.  Efficacy and safety of continuous local infusion of ropivacaine after retroperitoneoscopic live donor nephrectomy.

Authors:  A-R Biglarnia; G Tufveson; T Lorant; F Lennmyr; J Wadström
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

5.  Effectiveness of continuous wound infusion of local anesthetics after abdominal surgeries.

Authors:  Baskaran Dhanapal; Sarath Chandra Sistla; Ashok Shankar Badhe; Sheikh Manwar Ali; Niranjan T Ravichandran; Indira Galidevara
Journal:  J Surg Res       Date:  2016-12-29       Impact factor: 2.192

6.  Use of the ON-Q pain management system is associated with decreased postoperative analgesic requirement: double blind randomized placebo pilot study.

Authors:  Mirza K Baig; Oded Zmora; Jeannette Derdemezi; Eric G Weiss; Juan J Nogueras; Steven D Wexner
Journal:  J Am Coll Surg       Date:  2006-02       Impact factor: 6.113

7.  Major complications of epidural analgesia after surgery: results of a six-year survey.

Authors:  I W Christie; S McCabe
Journal:  Anaesthesia       Date:  2007-04       Impact factor: 6.955

8.  Wound infusion with local anaesthesia after laparotomy: a randomized controlled trial.

Authors:  Louis William Wang; Shing Wai Wong; Philip John Crowe; Kok Eng Khor; Grazyna Jastrzab; Andrew David Parasyn; William Robert Walsh
Journal:  ANZ J Surg       Date:  2010-11       Impact factor: 1.872

9.  The inhibitory effects of local anaesthetics on the vascular flare responses to bradykinin and substance P in human skin.

Authors:  M P Dias; D J Newton; G A McLeod; F Khan; J J F Belch
Journal:  Anaesthesia       Date:  2008-02       Impact factor: 6.955

10.  Effectiveness of continuous wound infusion of 0.5% ropivacaine by On-Q pain relief system for postoperative pain management after open nephrectomy.

Authors:  E Forastiere; M Sofra; D Giannarelli; L Fabrizi; G Simone
Journal:  Br J Anaesth       Date:  2008-12       Impact factor: 9.166

View more
  1 in total

1.  Ultrasound-guided preperitoneal phenol neurolysis for palliative pain.

Authors:  María Del Pilar Ascensio-Mercado; Andreís Rocha-Romero; Mario Fajardo Pérez
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.